Quick Answer
REVELATION BIOSCIENCES, INC. reported Stockholders Equity of $8.86 million for fiscal year 2025.
REVELATION BIOSCIENCES, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $8.86M | +88.2% |
| 2024 | $4.71M | -29.2% |
| 2023 | $6.65M | +531.6% |
| 2022 | $1.05M | +1158.1% |
| 2021 | -$99.5K | -102.9% |
| 2020 | $3.41M | +93877.5% |
| 2019 | -$3.6K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $11.00M | +311.5% | +187.6% |
| June 30, 2025 | $3.83M | +235.5% | +32.8% |
| March 31, 2025 | $2.88M | -69.6% | -38.8% |
| December 31, 2024 | $4.71M | -29.2% | +76.1% |
| September 30, 2024 | $2.67M | -69.7% | +134.4% |
| June 30, 2024 | $1.14M | -90.0% | -88.0% |
| March 31, 2024 | $9.47M | -5.4% | +42.5% |
| December 31, 2023 | $6.65M | +531.6% | -24.6% |
- REVELATION BIOSCIENCES, INC. showed an increase of +88.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2019–2025 period, REVELATION BIOSCIENCES, INC.’s stockholders equity has grown by 243667.8% (from -$3.6 thousand to $8.86 million).
- The most recent figure is from REVELATION BIOSCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: